Dejan Micic to Neoplasms
This is a "connection" page, showing publications Dejan Micic has written about Neoplasms.
Connection Strength
1.077
-
Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction. Support Care Cancer. 2024 Mar 04; 32(3):206.
Score: 0.334
-
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis. J Hematol Oncol. 2022 02 05; 15(1):15.
Score: 0.290
-
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Gastroenterol. 2019 01; 53(1):e1-e11.
Score: 0.234
-
Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC. Ann Surg Oncol. 2021 Nov; 28(12):6955-6964.
Score: 0.069
-
Risk of Cancers in Patients with Pediatric Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Pediatr. 2021 02; 229:102-117.e36.
Score: 0.066
-
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
Score: 0.054
-
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Proc Natl Acad Sci U S A. 2009 Nov 17; 106(46):19455-60.
Score: 0.031